An update on the technology from the busiest Gamma Knife center in the Americas
Supporting patients during pregnancy and beyond
Real-world applications in clinical documentation and trial matching
Q&A with new classical hematology program leader
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Patient with TP53 mutation achieves full response with targeted therapy
Study also finds that 26% of children with cancer have mutations in DNA repair genes
Concurrent treatment necessary for addressing progressive disease and infection
Psychosocial oncology offers a path forward
A conversation with Marcelo Pasquini, MD
Percutaneous stabilization can increase mobility without disrupting cancer treatment
Advertisement
Advertisement